Clinuvel Announces Ongoing Share Buy-Back
Company Announcements

Clinuvel Announces Ongoing Share Buy-Back

Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.

Clinuvel Pharmaceuticals Limited has updated the market with a notification of an on-market buy-back, where a total of 64,990 ordinary shares had been repurchased before the previous day, and an additional 1,600 shares were bought back on the previous day. The announcement, dated September 27, 2024, is part of the company’s ongoing strategy to manage its share capital.

For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Announces Director Change and Shareholdings
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Reports Key AGM Resolutions
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Faces Challenges Amid Market Dynamics
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App